Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Aubagio
Biotech
Roche reports pivotal MS win, but deaths add to safety questions
The discovery that more patients died on fenebrutinib than on the control drug has spurred further analyses by Roche.
Nick Paul Taylor
Mar 2, 2026 6:00am
Janssen sends off NDA for new multiple sclerosis drug ponesimod
Mar 20, 2020 8:00am
MedDay's multiple sclerosis drug a bust in phase 3
Mar 10, 2020 5:24pm
J&J multiple sclerosis hopeful tops Sanofi's Aubagio in phase 3
Sep 11, 2019 6:03pm
